VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)

首圖 ST GALLEN, Switzerland & MOUNTAIN VIEW, Calif. — (BUSINESS WIRE) — Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/…


發佈留言